Safety of topical sildenafil cream, 3.6% in a randomized, placebo-controlled trial for the treatment of female sexual arousal disorder

Endometriosis

Efficacy and safety of estetrol (E4) 15 mg/drospirenone (DRSP) 3 mg combination in a cyclic regimen for the treatment of endometriosis-associated pain and objective gynecological findings: A multicenter, placebo-controlled, double-blind, randomized study

Fertil Steril

Harada T, Kobayashi T, Hirakawa A, Takayanagi T, Nogami M, Mochiyama T, Hirayama M, Foidart JM, Osuga Y

doi: 10.1016/j.fertnstert.2024.07.011

Urinary Incontinence

Efficacy and Safety of TAS-303 in Female Patients With Stress Urinary Incontinence: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial

J Urol

Takahashi S, Kato K, Yokoyama O, Takei M, Gotoh M

doi: 10.1097/JU.0000000000004024

Reproductive Health

Efficacy and safety of estetrol (E4) 15 mg/drospirenone (DRSP) 3 mg combination in a cyclic regimen for the treatment of primary and secondary dysmenorrhea: A multicenter, placebo-controlled, double-blind, randomized study

Fertil Steril

Osuga Y, Kobayashi T, Hirakawa A, Takayanagi T, Nogami M, Tayzar K, Mochiyama T, Hirayama M, Foidart JM, Harada T

doi: 10.1016/j.fertnstert.2024.11.003

Benign Prostatic Hyperplasia (BPH)

Efficacy and Safety of Vibegron for Persistent Symptoms of Overactive Bladder in Men Being Pharmacologically Treated for Benign Prostatic Hyperplasia: Results From the Phase 3 Randomized Controlled COURAGE Trial

J Urol

Staskin D, Owens-Grillo J, Thomas E, Rovner E, Cline K, Mujais S

doi: 10.1097/JU.0000000000003999

Overactive BladderUrinary Incontinence

Gene Therapy With URO-902 (pVAX/hSlo) for the Treatment of Female Patients With Overactive Bladder and Urge Urinary Incontinence: Safety and Efficacy From a Randomized Phase 2a Trial

J Urol

Enemchukwu EA, Kalota S, Robertson K, Ge S, Lu J, Badger H, Mujais S, Peters KM

doi: 10.1097/JU.0000000000004373

Menopause

Safety of Fezolinetant for Treatment of Moderate to Severe Vasomotor Symptoms Due to Menopause: Pooled Analysis of Three Randomized Phase 3 Studies

Adv Ther

Kagan R, Cano A, Nappi RE, English ML, Mancuso S, Wu X, Ottery FD

doi: 10.1007/s12325-024-03073-8

Urinary Incontinence

Double-blinded randomized controlled trial of Erbium-YAG Laser to treat Female Stress Urinary Incontinence

Am J Obstet Gynecol

Lee P, Perruzza D, Edell H, Jarvi S, Kim K, Sultana R, Alavi N, Kiss A, Cao X, Gagnon LH, Bodley J, Carr L, Herschorn S, Kung R

doi: 10.1016/j.ajog.2024.11.021

Further Publications Urology

Evaluating the efficacy and safety of platelet-rich plasma injection for erectile dysfunction: a systematic review and meta-analysis of randomized controlled trials

Sex Med Rev

Deabes M, Deameh MG, Bani Irshid BA, Al Darraji AH, Serag I, Almosilhy NA, Dwidar A, Aldemerdash MA, Shahin HN

doi: 10.1093/sxmrev/qeae018

Further Publications Urology

The effect of combination treatment with low-intensity shockwave therapy and daily tadalafil on severe erectile dysfunction: a double-blind, randomized, sham-controlled clinical trial

J Sex Med

Kalyvianakis D, Mykoniatis I, Pyrgidis N, Kapoteli P, Zilotis F, Hatzichristou D

doi: 10.1093/jsxmed/qdae038

Related content

Efficacy and safety of estetrol (E4) 15 mg/drospirenone (DRSP) 3 mg combination in a cyclic regimen for the treatment of endometriosis-associated pain and objective gynecological findings: A multicenter, placebo-controlled, double-blind, randomized study

Efficacy and Safety of TAS-303 in Female Patients With Stress Urinary Incontinence: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial

Efficacy and safety of estetrol (E4) 15 mg/drospirenone (DRSP) 3 mg combination in a cyclic regimen for the treatment of primary and secondary dysmenorrhea: A multicenter, placebo-controlled, double-blind, randomized study

Efficacy and Safety of Vibegron for Persistent Symptoms of Overactive Bladder in Men Being Pharmacologically Treated for Benign Prostatic Hyperplasia: Results From the Phase 3 Randomized Controlled COURAGE Trial

Gene Therapy With URO-902 (pVAX/hSlo) for the Treatment of Female Patients With Overactive Bladder and Urge Urinary Incontinence: Safety and Efficacy From a Randomized Phase 2a Trial

Safety of Fezolinetant for Treatment of Moderate to Severe Vasomotor Symptoms Due to Menopause: Pooled Analysis of Three Randomized Phase 3 Studies

Double-blinded randomized controlled trial of Erbium-YAG Laser to treat Female Stress Urinary Incontinence

Evaluating the efficacy and safety of platelet-rich plasma injection for erectile dysfunction: a systematic review and meta-analysis of randomized controlled trials

The effect of combination treatment with low-intensity shockwave therapy and daily tadalafil on severe erectile dysfunction: a double-blind, randomized, sham-controlled clinical trial